Physician profile
Ross C Bartley
NPI 1750794988
$16,295.19
in general payments reported to CMS, 2019-2025
35 companies · $1,423 in 2025
The $1,423 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,352 · 2020: $638 · 2021: $3,670 · 2022: $1,646 · 2023: $1,299 · 2024: $2,267 · 2025: $1,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,008 · Travel and Lodging: $583 · Education: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,008.28 |
| Travel and Lodging | $582.64 |
| Education | $397.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,477.71 | 2019 | |
| Stryker Corporation | $2,896.24 | 2021-2025 | Hoffmann, Infinity, Prostep Mica |
| Titan Surgical Group, LLC | $2,501.45 | 2021-2024 | |
| Treace Medical Concepts, INC. | $2,078.64 | 2019-2025 | |
| In2bones USA, LLC | $1,062.64 | 2021 | |
| Orthofix Medical, INC. | $822.23 | 2021-2025 | Truelok |
| Organogenesis INC. | $572.58 | 2021-2025 | Affinity, Puraply Wound Matrix, Apligraf |
| Kerecis Limited | $439.69 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Zimmer Biomet Holdings, INC. | $322.88 | 2019-2021 | |
| Wright Medical Technology, INC. | $292.40 | 2019-2020 | |
| Integra Lifesciences Corporation | $281.71 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $170.37 | 2019 | |
| Horizon Therapeutics Plc | $160.45 | 2019 | |
| Smith+Nephew, INC. | $143.86 | 2019-2024 | Collagenase Santyl, Grafix Pl |
| Voom Medical Devices, INC. | $128.33 | 2024 | Revcon |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $115.50 | 2022-2025 | Motoband, Motoband Cp |
| Mimedx Group, INC. | $94.30 | 2024-2025 | |
| Restor3d, INC. | $93.82 | 2025 | |
| Acumed LLC | $89.89 | 2024-2025 | Acumed, Osteomed, Innate Implant |
| Novastep INC. | $80.11 | 2022 | |
| Tenex Health INC. | $69.78 | 2021 | |
| Convatec INC. | $64.10 | 2023-2024 | |
| Acera Surgical, INC. | $45.27 | 2022 | |
| Averitas Pharma INC. | $36.54 | 2023 | Qutenza |
| Deroyal Industries, INC. | $33.94 | 2022 | |
| Aroa Biosurgery Incorporated | $33.48 | 2023 | |
| Abbvie INC. | $32.66 | 2023 | Dalvance |
| Paratek Pharmaceuticals, INC. | $31.73 | 2024-2025 | Nuzyra |
| Janssen Pharmaceuticals, INC | $30.60 | 2021 | |
| Polynovo North America LLC | $21.09 | 2025 | Novosorb Btm |
| Solventum Corporation | $19.53 | 2025 | V.A.C.Ulta, Prevena |
| Kci USA, INC. | $15.24 | 2023 | Promogran Prisma, Activ.A.C. Ion Progress |
| Biocomposites INC | $13.05 | 2024 | |
| Hospira, INC. | $12.26 | 2022 | |
| Merck Sharp & Dohme LLC | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Bartley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.